about
Besifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial InfectionsLevofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.Proteomic analysis of keratitis-associated Pseudomonas aeruginosa.Flashes, floaters, and oral fluoroquinolones: is retinal detachment a worry?Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.Pharmaceutical impurities--a mini-review.Topical flagellin protects the injured corneas from Pseudomonas aeruginosa infection.Corneal plaque containing levofloxacin in a dog.The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulcerationSustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials.Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations.Pharmacokinetics and pharmacodynamics of antibacterial agents.Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing techniqueA mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.Recent trends in the impurity profile of pharmaceuticals.Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl Delivery.Pharmacological treatment for infectious corneal ulcers.Release of Moxifloxacin from Contact Lenses Using an In Vitro Eye Model: Impact of Artificial Tear Fluid Composition and Mechanical Rubbing.Postoperative lomefloxacin 0.3% prophylaxis in strabismus surgery.Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin.Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective.Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats.A Rapid Extraction Method to Quantify Drug Uptake in Contact Lenses.
P2860
Q26752242-2E18BE5B-57BB-48AF-AD88-EDB36116DAF6Q33836612-5DD339EC-79C6-4AF6-A2B8-B34565562450Q34127752-CBAF8B2E-3539-4DAF-BA7B-480021E316A0Q34281801-AD3554F9-8730-4416-9357-01EE49487F05Q34938184-D8BCEBE4-EDFF-4125-8A2C-8ADFBCC1C436Q35198956-14CFC060-BCFB-46CC-9639-2DEDDF977F61Q35328441-AA96216E-586F-4349-93B6-040CC98CFC4DQ35566243-1BDA9395-9719-4425-9CC9-2FC64E1E25C9Q35591605-2B8578B7-DD56-40C6-9E5A-AA736453354EQ35921444-9153DBF4-28AE-46AE-B4EF-0B335CC9F3EFQ36352232-972C088B-5154-4832-B238-CFF8546A7B8CQ36911111-8F11EC4B-019D-4A1B-AFCA-4835B3AB2CEEQ37577369-FEBFB5C7-F969-4647-81DC-83E4DCBE157DQ37653431-38427BBF-30A9-4DBF-9160-A163F29FC6FFQ38651665-359DB377-DF6C-4881-B1B0-D96DF8B18001Q39955572-52A2D12E-CF76-417C-89AD-95AD998F170FQ40303870-E245651C-806C-4725-8423-5CC866E6E953Q42238214-4DCF7B98-61D2-451F-BD72-762FF1F219E7Q42273313-E9C25B0F-CBEB-4979-BF35-13E41A1D807CQ42369732-A243BC1C-4D54-4652-856E-AC8032C0F776Q46318103-CF2E324C-BC20-406B-92FF-52C1B827C875Q46922696-43D9697D-4D3F-49D1-8AF4-04E1F96D08DFQ47769461-E8563AC6-2E12-4DE9-9A9A-C990291B0A44Q48313289-7865B427-C7CC-4C7D-AFCF-F49D05B73B2BQ52620262-B47563DD-F8A5-4D80-AF67-FA72578B29D0
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Fluoroquinolones: place in ocular therapy.
@ast
Fluoroquinolones: place in ocular therapy.
@en
Fluoroquinolones: place in ocular therapy.
@nl
type
label
Fluoroquinolones: place in ocular therapy.
@ast
Fluoroquinolones: place in ocular therapy.
@en
Fluoroquinolones: place in ocular therapy.
@nl
prefLabel
Fluoroquinolones: place in ocular therapy.
@ast
Fluoroquinolones: place in ocular therapy.
@en
Fluoroquinolones: place in ocular therapy.
@nl
P2093
P1433
P1476
Fluoroquinolones: place in ocular therapy.
@en
P2093
P304
P356
10.2165/00003495-200161060-00004
P577
2001-01-01T00:00:00Z
P6179
1009017790